What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?

MLA

Luca Malorni, et al. “What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?” Clinical Cancer Research, vol. 26, June 2020, pp. 2783–88. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2749003e867115380d103c3a7e16edf4&authtype=sso&custid=ns315887.

APA

Luca Malorni, Rafael Caparica, Lisa A. Carey, Martine Piccart, Aleix Prat, & Mariana Brandão. (2020). What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer? Clinical Cancer Research, 26, 2783–2788.

Chicago

Luca Malorni, Rafael Caparica, Lisa A. Carey, Martine Piccart, Aleix Prat, and Mariana Brandão. 2020. “What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?” Clinical Cancer Research 26 (June): 2783–88. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2749003e867115380d103c3a7e16edf4&authtype=sso&custid=ns315887.